Search results for "fibrosis"

showing 10 items of 901 documents

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) …

2017

Background HCV GT4 accounts for up to 20% of HCV infections worldwide. Simeprevir, given for 12 weeks as part of a 24- or 48-week combination regimen with PR is approved for the treatment of chronic HCV GT4 infection. Primary study objectives were assessment of efficacy and safety of simeprevir plus PR in treatment-naïve patients with HCV GT4 treated for 12 weeks. Primary efficacy outcome was sustained virologic response 12 weeks post-treatment (SVR12). Additional objectives included investigation of potential associations of rapid virologic response and baseline factors with SVR12. Methods This multicentre, open-label, single-arm study (NCT01846832) evaluated efficacy and safety of simepre…

SimeprevirMalePsychologie appliquéeFetge - MalaltiesHepacivirusGastroenterologyPolyethylene GlycolPolyethylene Glycols0302 clinical medicinelcsh:Science61 - MedicinaLiver DiseasesSciences bio-médicales et agricolesCirrhosisInterferonLiver Fibrosis030211 gastroenterology & hepatologyDrug Therapy CombinationViral loadBiologieHumanmedicine.medical_specialtyCiències multidisciplinàriesGenotypeSaudi ArabiaAlpha interferon:Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores]Gastroenterology and HepatologyMicrobiologyAntiviral Agents03 medical and health sciencesHumansAgedMedicine and health sciencesHepaciviruFlavivirusesInterleukinslcsh:ROrganismsInterleukinmedicine.diseaseRegimen:Digestive System Diseases::Liver Diseases [DISEASES]chemistryImmunologylcsh:QMedicaments - AdministracióDevelopmental BiologyRNA viruseslcsh:Medicinemedicine.disease_cause:Other subheadings::Other subheadings::/drug therapy [Other subheadings]Geographical Locationschemistry.chemical_compoundSimeprevirHospital Universitari Vall d’Hebron030212 general & internal medicinePathology and laboratory medicineMultidisciplinaryHepatitis C virusHepatitis CRecombinant ProteinMedical microbiologyMiddle AgedViral LoadHepatitis CRecombinant Proteins:enfermedades del sistema digestivo::enfermedades hepáticas [ENFERMEDADES]EuropeResearch DesignVirusesFemalePathogensResearch ArticleAdultAsiaAdolescentClinical Research DesignHepatitis C virusResearch and Analysis MethodsYoung AdultInternal medicineRibavirinmedicineddc:610Rapid Virologic ResponseAntiviral AgentBiology and life sciencesbusiness.industryRibavirinViral pathogensInterferon-alphaFibrosisHepatitis virusesMicrobial pathogensPeople and PlacesAdverse EventsInterferonsbusinessPLoS ONE
researchProduct

Future perspectives in hepatocellular carcinoma.

2010

Hepatocellular carcinoma (HCC) is one of the most common and lethal malignancies worldwide. Due to late diagnosis and advanced underlying liver cirrhosis, only limited treatment options with marginal clinical benefits have been available in up to 70% of patients. However, major progress has been achieved with regard to surveillance, early diagnosis, and multimodal treatment approaches during the last years leading to an improvement in prognosis. Particularly, the increasing knowledge of molecular hepatocarcinogenesis today provides the opportunity for targeted therapy. The multikinase inhibitor sorafenib has broadened the therapeutic horizon for patients with advanced disease and is current…

SorafenibOncologyAblation Techniquesmedicine.medical_specialtyCarcinoma Hepatocellularmedicine.medical_treatmentLiver transplantationGastroenterologyTargeted therapyInternal medicinemedicineAdjuvant therapyCombined Modality TherapyHumansChemoembolization TherapeuticPrecision MedicineTranscatheter arterial chemoembolizationProtein Kinase InhibitorsHepatologybusiness.industryLiver NeoplasmsGastroenterologymedicine.diseaseCombined Modality TherapyFibrosisLiver TransplantationHepatocellular carcinomaPersonalized medicinebusinessmedicine.drugForecastingDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Physiotherapy adherence and perception in patients with cystic fibrosis: A descriptive study

2015

Background: Cystic fibrosis (CF) is a chronic and multisystem disease in which respiratory physiotherapy (RP) has revealed as one of the main pillars of treatment. Aim: This study was aimed at assessing the convergent validity and the internal consistency of a new instrument (CAP-FISIO questionnaire) to measure the adherence and the perception of RP in patients with CF. In addition, we inquired into the correlation of the CAP-FISIO questionnaire outcomes with degrees of self-efficacy and coping of the patients. Methods: This is a descriptive cross-sectional pilot study. Patients with CF were assessed in one temporal moment: 1) anthropometrics; 2) forced Spirometry; 3) adherence and percepti…

SpirometryCoping (psychology)medicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedia_common.quotation_subjectAnthropometrymedicine.diseaseCystic fibrosisFEV1/FVC ratioConvergent validityPerceptionPhysical therapyMedicineIn patientbusinessmedia_common9.2 Physiotherapists
researchProduct

Genome-wide association analysis identifies six new loci associated with forced vital capacity

2014

Forced vital capacity (FVC), a spirometric measure of pulmonary function, reflects lung volume and is used to diagnose and monitor lung diseases. We performed genome-wide association study meta-analysis of FVC in 52,253 individuals from 26 studies and followed up the top associations in 32,917 additional individuals of European ancestry. We found six new regions associated at genome-wide significance (P <5 x 10(-8)) with FVC in or near EFEMP1, BMP6, MIR129-2-HSD17B12, PRDM11, WWOX and KCNJ2. Two loci previously associated with spirometric measures (GSTCD and PTCH1) were related to FVC. Newly implicated regions were followed up in samples from African-American, Korean, Chinese and Hispani…

SpirometryLung DiseasesVital capacityQuantitative Trait LociVital CapacityGenome-wide association studyBiologyPolymorphism Single NucleotideArticleDISEASEPulmonary function testingCohort StudiesFEV1/FVC ratioIdiopathic pulmonary fibrosisSDG 3 - Good Health and Well-beingMeta-Analysis as TopicForced Expiratory VolumeDatabases GeneticGeneticsmedicineHumansRestrictive lung diseaseLung volumesGenetic Predisposition to Diseaselung; spriometry; SNP; geneGENE-EXPRESSIONGeneticsmedicine.diagnostic_testGenome HumanHERITABILITYHEALTHY TWINMORTALITYta3141respiratory systemmedicine.diseasePrognosis3. Good healthRespiratory Function Testsrespiratory tract diseasesFAMILYLUNG-FUNCTIONGenetic LociSpirometryImmunologyCELLSIDIOPATHIC PULMONARY-FIBROSISTRAITSFollow-Up StudiesGenome-Wide Association StudyNature Genetics
researchProduct

3 He-MRI-based vs. conventional determination of lung volumes in patients after unilateral lung transplantation: a new approach to regional spirometry

2002

Background: To use 3Helium (3He)-MRI in patients with unilateral lung grafts to assess the contributions of graft and native lung to total ventilated lung volume, and second to compare conventional measurements of intrapulmonary gas volume (spirometry, body plethysmography) with image-based volumetry of ventilated lung parenchyma visualized by hyperpolarized 3He-MRI. Methods: With Ethics Committee approval, five patients with single lung transplantation (SLTX) for idiopathic pulmonary fibrosis (IPF) underwent both conventional pulmonary function testing (PFT) and 3He-MRI of the lung. Intrapulmonary gas volume (GV) during the inspiratory breathhold for 3He-MRI was calculated from measured fu…

Spirometrymedicine.medical_specialtyLungmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentGeneral Medicinerespiratory systemmedicine.diseaserespiratory tract diseasesPulmonary function testingTransplantationIdiopathic pulmonary fibrosisAnesthesiology and Pain MedicineFunctional residual capacitymedicine.anatomical_structuremedicineLung transplantationLung volumesRadiologybusinessActa Anaesthesiologica Scandinavica
researchProduct

Performance of Radiomics Features in the Quantification of Idiopathic Pulmonary Fibrosis from HRCT.

2020

Background: Our study assesses the diagnostic value of different features extracted from high resolution computed tomography (HRCT) images of patients with idiopathic pulmonary fibrosis. These features are investigated over a range of HRCT lung volume measurements (in Hounsfield Units) for which no prior study has yet been published. In particular, we provide a comparison of their diagnostic value at different Hounsfield Unit (HU) thresholds, including corresponding pulmonary functional tests. Methods: We consider thirty-two patients retrospectively for whom both HRCT examinations and spirometry tests were available. First, we analyse the HRCT histogram to extract quantitative lung fibrosis…

Spirometrymusculoskeletal diseasesHigh-resolution computed tomographyhigh resolution computed tomographyClinical Biochemistry-Article030218 nuclear medicine & medical imagingPulmonary function testing03 medical and health sciencesIdiopathic pulmonary fibrosis0302 clinical medicineRadiomicsHounsfield scalemedicineSettore ING-INF/05 - Sistemi Di Elaborazione Delle Informazionilcsh:R5-920Lungmedicine.diagnostic_testbusiness.industryLung fibrosisrespiratory systemmedicine.diseaseidiopathic pulmonary fibrosisrespiratory tract diseasesmedicine.anatomical_structure030228 respiratory systemradiomicslcsh:Medicine (General)businessNuclear medicineDiagnostics (Basel, Switzerland)
researchProduct

About Objective 3-D Analysis of Airway Geometry in Computerized Tomography

2008

The technology of multislice X-ray computed tomography (MSCT) provides volume data sets with approximately isotropic resolution, which permits a noninvasive 3-D measurement and quantification of airway geometry. In different diseases, like emphysema, chronic obstructive pulmonary disease (COPD), or cystic fribrosis, changes in lung parenchyma are associated with an increase in airway wall thickness. In this paper, we describe an objective measuring method of the airway geometry in the 3-D space. The limited spatial resolution of clinical CT scanners in comparison to thin structures like airway walls causes difficulties in the measurement of the density and the thickness of these structures.…

SwineComputer sciencePulmonary diseaseComputed tomographyGeometrySensitivity and SpecificityCystic fibrosisImaging phantomImaging Three-DimensionalParenchymamedicineAnimalsMultisliceElectrical and Electronic EngineeringQuantitative computed tomographyLungImage resolutionCOPDLungRadiological and Ultrasound Technologymedicine.diagnostic_testPhantoms ImagingReproducibility of ResultsBronchographyComputational geometrymedicine.diseaserespiratory tract diseasesComputer Science ApplicationsRadiographic Image Enhancementmedicine.anatomical_structureAirway wallRadiographic Image Interpretation Computer-AssistedTomographyTomography X-Ray ComputedAirwayAlgorithmsSoftwareIEEE Transactions on Medical Imaging
researchProduct

Hepatitis C virus and cardiovascular: A review

2017

Graphical abstract

Systemic diseaseCirrhosisFibrosiHepatitis C virusReviewmedicine.disease_causeVirus03 medical and health sciences0302 clinical medicineInsulin resistanceFibrosismedicine030212 general & internal medicineGenerallcsh:Science (General)ComputingMethodologies_COMPUTERGRAPHICSlcsh:R5-920MultidisciplinaryHigh prevalencebusiness.industryvirus diseasesmedicine.diseaseCardiovascular riskAtherosclerosisFibrosisdigestive system diseasesDeathAtherosclerosiImmunologyHCV030211 gastroenterology & hepatologyHearthSteatosisbusinesslcsh:Medicine (General)lcsh:Q1-390Journal of Advanced Research
researchProduct

Using Machine Learning to Characterize Atrial Fibrotic Substrate From Intracardiac Signals With a Hybrid in silico and in vivo Dataset

2021

[EN] In patients with atrial fibrillation, intracardiac electrogram signal amplitude is known to decrease with increased structural tissue remodeling, referred to as fibrosis. In addition to the isolation of the pulmonary veins, fibrotic sites are considered a suitable target for catheter ablation. However, it remains an open challenge to find fibrotic areas and to differentiate their density and transmurality. This study aims to identify the volume fraction and transmurality of fibrosis in the atrial substrate. Simulated cardiac electrograms, combined with a generalized model of clinical noise, reproduce clinically measured signals. Our hybrid dataset approach combines in silico and clinic…

TECNOLOGIA ELECTRONICABidomainMachine learningDensityCardiac modelingddc:620Atrial fibrillationFibrosisEngineering & allied operationsTransmurality
researchProduct

Role of cyclooxygenase pathways in bowel fibrotic remodelling in a murine model of experimental colitis

2022

Abstract Objective Gut fibrosis occurs under chronic inflammation. This study examined the effects of different cyclooxygenase (COX) inhibitors on fibrosis in the inflamed colon. Methods Colitis was induced by 2,4-dinitrobenzenesulfonic acid (DNBS) in albino male Sprague–Dawley rats. After 6, 12 and 18 days, macroscopic and microscopic damage, collagen and elastic fibre content were examined. At day 6, pro-fibrotic factors (collagen I and III, hydroxyproline, fibronectin, matrix metalloproteinase-2 and -9), transforming growth factor-beta (TGF-β) signalling [TGF-β, Ras homolog gene family member A (RhoA), phosphorylated small mother against decapentaplegic (pSMAD)-2 and -6] and peristalsis …

TGF-βPharmacologyfibrosis cyclooxygenase inhibitor gutinflammatory bowel diseasefibrosiscyclooxygenase inhibitorgutPharmaceutical ScienceSMADCyclooxygenaseJournal of Pharmacy and Pharmacology
researchProduct